Dependence of cell survival on iododeoxyuridine concentration in 35-KeV photon-activated auger electron radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 255-261

  Dugas, Joseph P ^a,c   Varnes, Marie E ^a,b   Sajo, Erno ^a   Welch, Christopher E ^a   Ham, Kyungmin ^a   Hogstrom, Kenneth R ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b MARY BIRD PERKINS CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Auger electron radiotherapy; Chinese hamster ovary cell irradiation; Monochromatic synchrotron x rays; Photon activation therapy; Radiation sensitizer iododeoxyuridine

Indexed keywords

AUGER ELECTRON RADIOTHERAPY; CHINESE HAMSTER OVARY CELLS; MONOCHROMATIC SYNCHROTRON X-RAYS; PHOTON ACTIVATION THERAPY; RADIATION SENSITIZER IODODEOXYURIDINE;

AUGER ELECTRON SPECTROSCOPY; AUGERS; DNA; ELECTRONS; IRRADIATION; MONOCHROMATORS; RADIATION EFFECTS; RADIOTHERAPY; SYNCHROTRONS; X RAYS;

PHOTONS;

IDOXURIDINE; THYMIDINE;

ANIMAL CELL; ARTICLE; AUGER ELECTRON SPECTROSCOPY; CELL SURVIVAL; CHO CELL; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; NONHUMAN; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION RESPONSE;

ANIMALS; CELL SURVIVAL; CHI-SQUARE DISTRIBUTION; CHO CELLS; CRICETINAE; CRICETULUS; DNA; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; IDOXURIDINE; LINEAR MODELS; PHOTONS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; THYMIDINE; TUMOR STEM CELL ASSAY;

EID: 78650021949     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.07.023     Document Type: Article

References (25)

1. 127I-deoxyuridine: Measurement of dose enhancement in cultured mammalian cells Proceedings of a Workshop on Photon Activation Therapy. Report No. BNL 51997 1985 Brookhaven National Laboratory Upton, NY 1 16
2. R.W. Miller, W. DeGraff, and T.J. Kinsella Evolution of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy Int J Radiat Oncol Biol Phys 13 1987 1193 1197
3. R. Nath, P. Bongiorni, and S. Rockwell Enhancement of IUdR radiosensitization by low energy photons Int J Radiat Oncol Biol Phys 13 1987 1071 1079
4. K. Shinohara, H. Nakano, and T. Hiraoka Photon factory activity report 4: 278 National Laboratory for High Energy Physics, KEK, Japan 1987
5. T.J. Kinsella An approach to the radiosensitization of human tumors Cancer J Sc Am 2 1996 184 193
6. M.W. Saif, G. Berk, and Y.-C. Cheng IPdR: A novel oral radiosensitizer Expert Opin Investig Drugs 16 2007 1415 1424
7. C.A. Schulz, M.P. Mehta, and B. Badie Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: A phase I clinical study Int J Radiat Oncol Biol Phys 59 2004 1107 1115
8. M. Deutsch, A.B. Rewers, and E.S. Redgate Intra-cerebral ventricular infusion of 5-iododeoxyuridine (IUdR) as a radiosensitizer in the treatment of rat glioma Int J Radiat Oncol Biol Phys 19 1990 85 87
9. K.J. Harrington, K.N. Syrigos, and P.S. Uster Targeted radiosensitization by pegylated liposome-encapsulated 3′, 5′-O-diapalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model Br J Cancer 91 2004 366 373
10. J. Rousseau, J.F. Adam, and P. Deman Intracerebral delivery of 5-iodo-2′-deoxyuridine in combination with synchrotron stereotactic radiation for therapy of the F98 glioma J Synchrotron Radiat 16 Pt 4 2009 573 581
11. T.J. Kinsella, K.A. Vielhuber, and K.A. Kunugi Pre-clinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2′- deoxyribose (IPdR) as a prodrug for IUdR-radiosensitization in U251 human glioblastoma xenografts Clin Cancer Res 6 2000 1468 1475
12. S.J. Karnas, V.V. Moiseenko, and E. Yu Monte Carlo simulations and measurement of DNA damage from x-ray-triggered Auger cascades in iododeoxyuridine (IUdR) Radiat Environ Biophys 40 2001 199 206
13. A.I. Kassis, and S.J. Adelstein Radiobiologic principles in radionuclide therapy J Nucl Med 46 Suppl 1 2005 4S 12S
14. J. Heilmann, G. Taucher-Scholz, and G. Kraft Induction of DNA double-strand breaks in CHO-K1 cells by carbon ions Int J Radiat Biol 68 1995 153 162
15. R.G. Fairchild, and V.P. Bond Photon activation therapy Strahlentherapie 169 1984 758 763
16. T.J. Kinsella, M.T. Kinsella, and Y. Seo 5-iodo-2-pyrimidone-2'- deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts Int J Radiat Oncol Biol Phys 69 2007 1254 1261
17. Y. Seo, T. Yan, and J.E. Schupp Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimdinone-2′-deoxyribose Clin Cancer Res 10 2004 7520 7528
18. B.H. Laster, W.C. Thomlinson, and R.G. Fairchild Photon activation of iododeoxyuridine: biological efficacy of Auger electrons Rad Res 133 1993 219 224
19. S. Corde, A. Joubert, and J.F. Adam Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds Br J Cancer 91 2004 544 551
20. S.J. Karnas, E. Yu, and R.C. McGarry Optimal photon energies for IUdR K-edge radiosensitization with filtered X-ray and radioisotope sources Phys Med Biol 44 1999 2537 2549
21. J.P. Dugas, S.D. Oves, and E. Sajo Monochromatic beam characterization for Auger electron dosimetry and radiotherapy Eur J Radiol 68 Suppl 2008 S137 S141
22. S.D. Oves, K.R. Hogstrom, and K. Ham Dosimetry intercomparison using a 35-keV X-ray synchrotron beam Eur J Radiol 68 Suppl 2008 S121 S125
23. P.R. Almond, P.J. Biggs, and B.M. Coursey AAPM's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams Med Phys 26 1999 1847 1870
24. T.S. Lawrence, M.A. Davis, and J. Maybaum The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure Int J Radiat Oncol Biol Phys 18 1990 1393 1398
25. J.A. Cook, J. Glass, and R. Lebovics Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine Cancer Res 52 1992 719 725